Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Vitamin D supplementation can improve skin health and appearance.

The document concludes that in Sri Lanka, 25 common plants are traditionally used as home remedies for various health issues due to their medicinal properties.

Testosterone significantly affects urination differences between male and female mice.

Finasteride reduces prostate size and PSA levels in young patients.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Keratins are crucial for cell stability, wound healing, and cancer diagnosis.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.